Antigenicity, stability, and reproducibility of Zika reporter virus particles for long-term applications

PLoS Neglected Tropical Diseases
J Charles WhitbeckBenjamin J Doranz

Abstract

The development of vaccines against flaviviruses, including Zika virus (ZIKV) and dengue virus (DENV), continues to be a major challenge, hindered by the lack of efficient and reliable methods for screening neutralizing activity of sera or antibodies. To address this need, we previously developed a plasmid-based, replication-incompetent DENV reporter virus particle (RVP) production system as an efficient and safe alternative to the Plaque Reduction Neutralization Test (PRNT). As part of the response to the 2015-2016 ZIKV outbreak, we developed pseudo-infectious ZIKV RVPs by modifying our DENV RVP system. The use of ZIKV RVPs as critical reagents in human clinical trials requires their further validation using stability and reproducibility metrics for large-scale applications. In the current study, we validated ZIKV RVPs using infectivity, neutralization, and enhancement assays with monoclonal antibodies (MAbs) and human ZIKV-positive patient serum. ZIKV RVPs are antigenically equivalent to live virus based on binding ELISA and neutralization results and are nonreplicating based on the results of live virus replication assays. We demonstrate reproducible neutralization titer data (NT50 values) across different RVP production lot...Continue Reading

References

Oct 1, 1990·Clinical Microbiology Reviews·E A Henchal, J R Putnak
Jun 6, 2000·Journal of Biomolecular Screening·J H ZhangK R Oldenburg
Apr 12, 2003·The Journal of Experimental Medicine·Boonrat TassaneetrithepMary A Marovich
Sep 1, 1952·Transactions of the Royal Society of Tropical Medicine and Hygiene·G W A DICKA J HADDOW
Sep 7, 2007·Journal of Clinical Microbiology·Annette A KrausAravinda M de Silva
Jul 23, 2008·Current Opinion in Microbiology·Rushika Perera, Richard J Kuhn
May 21, 2009·Journal of the American Chemical Society·Cheryl PaesBenjamin J Doranz
May 3, 2011·Emerging Infectious Diseases·Brian D FoyRobert B Tesh
Oct 26, 2013·Proceedings of the National Academy of Sciences of the United States of America·Elizabeth A ChristianBenjamin J Doranz
May 24, 2014·Immunology·Edgar Davidson, Benjamin J Doranz
Jun 19, 2015·Journal of Virology·Rodolphe HamelDorothée Missé
Jul 22, 2015·Lancet·Didier MussoDuane J Gubler
Feb 9, 2016·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Eskild PetersenAlimuddin Zumla
Mar 26, 2016·Science·Nuno Rodrigues FariaPedro F C Vasconcelos
Apr 2, 2016·Science·Devika SirohiRichard J Kuhn
Apr 20, 2016·Nature·Victor A KostyuchenkoShee-Mei Lok
May 4, 2016·The American Journal of Tropical Medicine and Hygiene·Morgan J HennesseyJ Erin Staples
Jun 19, 2016·BMJ : British Medical Journal·Michael McCarthy
Jun 25, 2016·Nature·Giovanna Barba-SpaethFélix A Rey
Jun 25, 2016·Nature Immunology·Wanwisa DejnirattisaiGavin R Screaton
Aug 3, 2016·Cell Reports·Kimberly A DowdTheodore C Pierson
Jan 10, 2017·Nature Structural & Molecular Biology·Vidya Mangala PrasadMichael G Rossmann
Jan 17, 2017·Clinical & Translational Immunology·Lauren M PaulSharon Isern
Feb 10, 2017·Microbiology and Molecular Biology Reviews : MMBR·Franz X Heinz, Karin Stiasny
Dec 22, 2017·The Journal of Infectious Diseases·Devika Sirohi, Richard J Kuhn
Jan 6, 2018·Virology·Leslie GooTheodore C Pierson

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
Infection
ELISA
Flow cytometry
PCR
biosensor

Software Mentioned

Integral Molecular
Shotgun Mutagenesis Epitope Mapping
GraphPad Prism
Integral

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.